Increasing numbers of cancer patients survive and live longer than five years after therapy,
but very often side effects of cancer treatment arise at same time. One of the side effects …

Chemobrain refers to a common sequela experienced by a substantial subset of cancer
patients exposed to chemotherapeutic treatment, a phenomenon that dramatically …

Among the potential adverse effects of breast cancer treatment, chemotherapy-related
cognitive impairment (CRCI) has gained increased attention in the past years. In this review …

Whilst chemotherapy is a widely used anti-cancer treatment, a subset of patients experience
cognitive decline. However, cancer type, treatment regimen, fatigue and anxiety can …

Chemotherapy-induced cognitive impairment (CICI) is an ill-defined complication of
chemotherapy treatment that places a significant psychosocial burden on survivors of cancer …

Doxorubicin (DOX) is known to cause cognitive impairments in patients submitted to long-
term chemotherapy (deficits also known as chemobrain). The present study investigated …

Paclitaxel (PTX) is one of the most commonly used chemotherapeutic agents for various
cancer diseases. Despite its advantages, PTX also causes behavioral deficits related to …

Chemotherapy-induced cognitive impairment (CICI) has been observed in a large fraction of
cancer survivors. Although many of the chemotherapeutic drugs do not cross the blood …

Cancer treatment is associated with long lasting cognitive impairment in cancer survivors.
This cognitive impairment is often termed cancer related cognitive impairment (CRCI) …

Objective This study aimed to investigate the effect of resveratrol (Res) on paclitaxel (PTX)-
induced cognitive impairment and elucidate the underlying molecular mechanisms. Methods …